BR100 Increased By (0.27%)
BR30 Increased By (0.26%)
KSE100 Increased By (0.25%)
KSE30 Increased By (0.24%)
BECO 5.51 Decreased By ▼ -0.03 (-0.54%)
BML 57.20 Increased By ▲ 0.11 (0.19%)
BOP 35.20 Decreased By ▼ -0.01 (-0.03%)
CNERGY 8.19 Decreased By ▼ -0.01 (-0.12%)
DCL 11.67 Increased By ▲ 0.03 (0.26%)
FCCL 56.65 Increased By ▲ 0.16 (0.28%)
FCSC 5.32 No Change ▼ 0.00 (0%)
FFL 18.08 Increased By ▲ 0.02 (0.11%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.10 Decreased By ▼ -0.09 (-0.8%)
KEL 8.29 Increased By ▲ 0.09 (1.1%)
KOSM 6.67 No Change ▼ 0.00 (0%)
MLCF 101.55 Increased By ▲ 0.79 (0.78%)
NBP 202.00 Decreased By ▼ -1.00 (-0.49%)
PACE 11.58 Increased By ▲ 0.09 (0.78%)
PAEL 43.57 Increased By ▲ 0.49 (1.14%)
PIAHCLA 27.10 Increased By ▲ 0.10 (0.37%)
PIBTL 17.96 Increased By ▲ 0.12 (0.67%)
PPL 244.30 Increased By ▲ 1.67 (0.69%)
PRL 35.94 Increased By ▲ 0.07 (0.2%)
PTC 66.01 Increased By ▲ 0.16 (0.24%)
SEARL 94.00 Increased By ▲ 0.42 (0.45%)
SSGC 33.13 Increased By ▲ 0.90 (2.79%)
TELE 9.05 Decreased By ▼ -0.06 (-0.66%)
THCCL 66.50 Increased By ▲ 0.01 (0.02%)
TPLP 10.80 Decreased By ▼ -0.15 (-1.37%)
TREET 25.80 Increased By ▲ 0.08 (0.31%)
TRG 66.00 Increased By ▲ 0.05 (0.08%)
WAVES 11.25 Increased By ▲ 0.09 (0.81%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
World

Valneva says UK rollout of COVID-19 vaccine could start in July-Sept

  • Valneva said in September that its vaccine would be available for use in Britain in the second half of 2021.
Published January 17, 2021 Updated January 17, 2021 08:59pm
By

LONDON: French drugmaker Valneva hopes its COVID-19 vaccine can start to be used in Britain between July and September, the company's chief executive was quoted as saying.

Valneva has agreed to provide Britain with 60 million doses of its vaccine, compared with 100 million doses of the shot from AstraZeneca and Oxford University. It is expected to need a two-dose regimen.

"We are days away from starting the commercial manufacturing," Thomas Lingelbach told The Mail on Sunday newspaper.

"We cannot release it without regulatory approval so we're in a little bit of a Catch-22 situation and there are certainly scenarios that we are currently discussing with the regulators," he added. "But we have already signed up to give priority to the UK and this is something we're currently working on."

Valneva said in September that its vaccine would be available for use in Britain in the second half of 2021.

Britain has launched Europe's fastest rollout of COVID-19 vaccines and its foreign minister Dominic Raab said on Sunday the government hoped to ease some lockdown restrictions in March.

Comments

Comments are closed for this article.